Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
100.50
+2.50 (2.55%)
May 29, 2026, 1:30 PM CST
16.32% (1Y)
| Market Cap | 156.41B +65.3% |
| Revenue (ttm) | 38.04M -6.0% |
| Net Income | -284.11M |
| EPS | -0.18 |
| Shares Out | 1.56B |
| PE Ratio | n/a |
| Forward PE | 32.29 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,838,972 |
| Open | 100.00 |
| Previous Close | 98.00 |
| Day's Range | 99.20 - 104.50 |
| 52-Week Range | 75.10 - 277.00 |
| Beta | 1.28 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 10, 2026 |